Paracentral Acute Middle Maculopathy Associated with Severe Anti-Mog (Myelin Oligodendrocyte Glycoprotein)-Positive Optic Neuritis

References

• Moura FC, Sato DK, Rimkus CM, et al. Anti-MOG (Myelin Oligodendrocyte Glycoprotein)-positive severe optic neuritis with optic disc ischaemia and macular star. Neuroophthalmology. December 2015;39(6):285–288. doi:10.3109/01658107.2015.1084332.
   PubMed Web of Science ®Google Scholar
• Parmley VC, Schiffman JS, Maitland CG, Miller NR, Dreyer RF, Hoyt WF. Does neuroretinitis rule out multiple sclerosis? Arch Neurol. October 1987;44(10):1045–1048. doi:10.1001/archneur.1987.00520220047015.
   PubMedGoogle Scholar
• Purvin V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuroophthalmol. March 2011;31(1):58–68. doi:10.1097/WNO.0b013e31820cf78a.
   PubMed Web of Science ®Google Scholar
• Budoff G, Bhagat N, Frohman L. Anti-myelin oligodendrocyte glycoprotein optic neuritis presenting with dense premacular hemorrhage. Ophthalmology. December 2019;126(12):1639. doi:10.1016/j.ophtha.2019.07.004.
   PubMed Web of Science ®Google Scholar
• Lukewich MK, Micieli JA. Venous stasis retinopathy secondary to myelin oligodendrocyte glycoprotein antibody-positive optic neuritis. Retin Cases Brief Rep. May 1, 2022;16(3):305–307. doi:10.1097/ICB.0000000000000977.
   PubMedGoogle Scholar
• Deschamps R, Vasseur V, Shor N, et al. A new association: acute macular neuroretinopathy in acute optic neuritis. Acta Ophthalmol. August 2019;97(5):e753–756. doi:10.1111/aos.14054.
   PubMed Web of Science ®Google Scholar
• Kon T, Hikichi H, Ueno T, et al. Myelin oligodendrocyte glycoprotein-IgG-positive recurrent bilateral optic papillitis with serous retinal detachment. Intern Med. November 15, 2018; 57(22): 3307–3312. 10.2169/internalmedicine.9840-17.
   PubMed Web of Science ®Google Scholar
• Lee AR, El-Dairi MA. Anti-myelin oligodendrocyte glycoprotein optic neuritis or neuroretinitis? JAMA Ophthalmol. January 10, 2018;136(10):e182928. doi:10.1001/jamaophthalmol.2018.2928.
   PubMed Web of Science ®Google Scholar
• Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. May 22, 2018; 90(21):e1858–1869.10.1212/WNL.0000000000005560.
   PubMed Web of Science ®Google Scholar
• Northey LC, Skalicky SE, Gurbaxani A, McCluskey PJ. Syphilitic uveitis and optic neuritis in Sydney, Australia. Br J Ophthalmol. September 2015;99(9):1215–1219. doi:10.1136/bjophthalmol-2014-306168.
   PubMed Web of Science ®Google Scholar
• Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol. September 2003;23(3):190–197. doi:10.1097/00041327-200309000-00002.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Consensus development conference practice guideline research support, non-U.S. Gov’t. Neurology. July 14, 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729.
   Google Scholar
• Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. February 11, 2014; 82(6): 474–481. 10.1212/WNL.0000000000000101.
   PubMed Web of Science ®Google Scholar
• Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflam. December 28, 2011; 8: 184. 10.1186/1742-2094-8-184.
   PubMed Web of Science ®Google Scholar
• Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflam. September 27, 2016; 13(1):280.10.1186/s12974-016-0718-0.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Flanagan EP, Jitprapaikulsan J, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195: 8–15. 10.1016/j.ajo.2018.07.020.
   PubMed Web of Science ®Google Scholar
• Ducloyer JB, Caignard A, Aidaoui R, et al. MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis. Br J Ophthalmol. 2020; 104(6):842–845.10.1136/bjophthalmol-2019-314845.
   PubMed Web of Science ®Google Scholar
• Sarraf D, Rahimy E, Fawzi AA, et al. Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol. October 2013;131(10):1275–1287. doi:10.1001/jamaophthalmol.2013.4056.
   PubMed Web of Science ®Google Scholar
• Yu S, Pang CE, Gong Y, et al. The spectrum of superficial and deep capillary ischemia in retinal artery occlusion. Am J Ophthalmol. January 2015;159(1): 53-63.e1-2. 10.1016/j.ajo.2014.09.027.
   Web of Science ®Google Scholar
• Nemiroff J, Kuehlewein L, Rahimy E, et al. Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography. Am J Ophthalmol. February 2016;162:121–132.e1. doi:10.1016/j.ajo.2015.10.026.
   PubMed Web of Science ®Google Scholar
• Scharf J, Freund KB, Sadda S, Sarraf D. Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res. 2021; 81: 100884. 10.1016/j.preteyeres.2020.100884.
   PubMed Web of Science ®Google Scholar
• Moura-Coelho N, Gaspar T, Ferreira JT, Dutra-Medeiros M, Cunha JP. Paracentral acute middle maculopathy-review of the literature. Graefes Arch Clin Exp Ophthalmol. December 2020;258(12):2583–2596. doi:10.1007/s00417-020-04826-1.
   PubMed Web of Science ®Google Scholar
• Creese K, Ong D, Sandhu SS, et al. Paracentral acute middle maculopathy as a finding in patients with severe vision loss following phacoemulsification cataract surgery. Clin Exp Ophthalmol. August 2017;45(6):598–605. doi:10.1111/ceo.12945.
   PubMed Web of Science ®Google Scholar